Device / Technology News

RSS

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has announced the European release of BIOTRONIK EHR DataSync. The software supports physicians, hospitals and clinics by integrating routine follow-up details, BIOTRONIK Home Monitoring remote follow-up information and data from the company's cardiac device programmers - ICS 3000 and the new programmer, Renamic, soon to be launched across Europe.

20 Oct 2010

New 3D Body Volume Index measurement calculates obesity risk

A new obesity measurement for the 21st Century, which can help identify individuals at risk of illness such as heart disease, strokes and diabetes, has been officially launched.

20 Oct 2010

Spectral commences pivotal Toraymyxin trial for severe sepsis

Spectral Diagnostics Inc., a Phase III company seeking FDA approval for its lead theranostics product for the treatment severe sepsis and septic shock, today announced initiation of its U.S. pivotal trial of Toraymyxin™, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, for patients with severe sepsis.

20 Oct 2010

454 Life Sciences enters co-promotional agreement with Fluidigm

454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary amplicon sample preparation and high-throughput sequencing platforms.

20 Oct 2010

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

The Washington Post: "A Maryland health information exchange that will allow hospitals, physicians, labs and radiology centers to share patient information within the state went live last week. Three hospitals, three radiology centers, Quest Diagnostics and the Laboratory Corp. of America are already participating in the exchange."

20 Oct 2010

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

Patients undergoing CIED (Cardiac Implantable Electronic Device) implantation with TYRX, Inc.'s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5% rate of successful implantation with an overall infection rate of 0.48% in the first 1.9 months following the procedure, as reported in newly published results of TYRX's COMMAND Clinical Study.

20 Oct 2010

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today it has entered into a license and distribution agreement for its Res-Q 60 BMC (Res-Q) System with BioParadox, Inc., a newly-formed regenerative medicine company focusing on point-of-care cardiovascular therapies.

20 Oct 2010

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Agendia, a world leader in molecular cancer diagnostics, announced today that it has established a contract with leading insurance provider Humana to reimburse for the company's MammaPrint test. Agendia's contract with Humana expands the coverage for MammaPrint by more than 17 million lives. In November 2009, Palmetto GBA, California's Part B Medicare administrator, established coding guidelines for MammaPrint, allowing healthcare providers from across the United States to submit claims for the test.

19 Oct 2010

Xenogenics acquires Ideal BioStent assets

MultiCell Technologies, Inc. and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western Technology Investment and Silicon Valley Bank. Xenogenics Corporation also entered into a worldwide exclusive license with Rutgers University for rights to certain intellectual property related to the Ideal™ BioStent.

19 Oct 2010

ReGen takes exception to FDA CDRH's plan to rescind Menaflex knee implant 510(k) clearance

ReGen Biologics Inc. is taking exception to the FDA's Center for Devices and Radiological Health's (CDRH) Thursday announcement of a plan to rescind the 510(k) clearance of the company's Menaflex knee implant.

19 Oct 2010

U.S. patient monitoring market to reach $4 billion by 2017: iData Research

According to a new report by iData Research the leading global authority in medical device and pharmaceutical market research, the U.S. patient monitoring market is expected to reach almost $4 billion by 2017.

19 Oct 2010

TearLab announces publication of CPT code for Osmolarity test

TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.

19 Oct 2010

Syneron launches VelaBABE device for women to reclaim pre-baby body

Syneron Medical Ltd., a leading medical aesthetic device innovator, is announcing their new VelaBABE promotion for women who want to reclaim their pre-baby body with help from VelaShape.

19 Oct 2010

Novartis to implement Veeva CRM for global deployments

Veeva Systems announced today that Novartis Pharmaceuticals AG, a world leader in the research, development, manufacturing and marketing of products to protect and improve health and well-being, has chosen Veeva CRM® for various global deployments.

19 Oct 2010

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

19 Oct 2010

MRG data finds factors that drive single-port laparoscopy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, a combination of increased volume from current practitioners and growth in the number of surgeons performing the technique will drive the single-port laparoscopy market to over 100% growth over the next year, and to high double-digit growth past 2011.

19 Oct 2010

getSTDtested.com introduces new payment options for preventative healthcare

Today getSTDtested.com, a leading online social health clinic, announced that consumers preferring alternative payments to credit cards for diagnostic health tests that they have ordered can now pay with cash in a simple web-to-store transaction using PayNearMe services at select convenience stores nationwide.

19 Oct 2010

PC Mall announces new solution for EHR adoption and achievement of meaningful use

PC Mall, Inc., whose healthcare expertise is marketed under the "HealthDynamix" brand, today announced a new solution that supports electronic health record adoption and assists physicians in achieving meaningful use as defined by the US government. Participating physicians will be able to take advantage of EHR funds recently allocated in the American Recovery and Reinvestment Act.

19 Oct 2010

Integration of XB-BIS and IPA software improve personalized medicine

Ingenuity Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPA software and XB Bio-Integration Suite (XB-BIS).

19 Oct 2010

HOYA ConBio's dentistry lasers to be featured at LVI's teaching facilities through 2013

HOYA ConBio™, a global leader in dental and aesthetic lasers, today announced an extension of its sponsorship agreement with the Las Vegas Institute for Advanced Dental Studies (LVI), the pioneer in live-patient, post-graduate dental training. The agreement ensures that VersaWave™ and DioDent™ Micro 980 lasers will continue to be featured at LVI's advanced teaching facilities through 2013.

19 Oct 2010

Device / Technology News

BIOTRONIK EHR DataSync software offers advanced patient management capabilities

New 3D Body Volume Index measurement calculates obesity risk

Spectral commences pivotal Toraymyxin trial for severe sepsis

454 Life Sciences enters co-promotional agreement with Fluidigm

State Roundup: Md.'s heath info exchange; LA to cut retiree health benefits; N.Y.'s mental health building boom

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

ThermoGenesis enters licensing agreement with BioParadox for Res-Q technology

Agendia establishes contract with Humana for coverage of MammaPrint breast cancer recurrence test

Xenogenics acquires Ideal BioStent assets

ReGen takes exception to FDA CDRH's plan to rescind Menaflex knee implant 510(k) clearance

U.S. patient monitoring market to reach $4 billion by 2017: iData Research

TearLab announces publication of CPT code for Osmolarity test

Syneron launches VelaBABE device for women to reclaim pre-baby body

Novartis to implement Veeva CRM for global deployments

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

MRG data finds factors that drive single-port laparoscopy market

getSTDtested.com introduces new payment options for preventative healthcare

PC Mall announces new solution for EHR adoption and achievement of meaningful use

Integration of XB-BIS and IPA software improve personalized medicine

HOYA ConBio's dentistry lasers to be featured at LVI's teaching facilities through 2013

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News